Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFenech, Anthony G.-
dc.contributor.authorGrech, Godfrey-
dc.identifier.citationFenech, A. G., & Grech, G. (2011). Pharmacogenetics : where do we stand? Journal of the Malta College of Pharmacy Practice, 17, 25-33.en_GB
dc.description.abstract“Our drugs do not work on most patients.” Such did Allen Roses, then worldwide vice-president of genetics at GlaxoSmithKline, greet his audience, during a scientific meeting in London in 2003.1 Nearly a decade has passed since then, and significant strides towards the development of genotype-guided prescribing have been made. Pharmacogenetics and pharmacogenomics are now an established area of pharmacology specialization, and they hold the promise of the key to personalized medicine, leading to safer and more effective patientfocussed therapeutic outcomes.en_GB
dc.publisherMalta College of Pharmacy Practiceen_GB
dc.subjectPersonalized medicineen_GB
dc.titlePharmacogenetics : where do we stand?en_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
Appears in Collections:JMCPP, Issue 17
JMCPP, Issue 17

Files in This Item:
File Description SizeFormat 
2011-17-5.pdfPharmacogenetics : where do we stand?102.79 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.